Allarity Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Allarity Therapeutics, Inc. (ALLR) had Convertible Notes Payable, Noncurrent of $1.32 million as of 2024-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2024-08-05
- 2024-06-30: Convertible Notes Payable, Noncurrent $1.32M.
- 2024-03-31: Convertible Notes Payable, Noncurrent $1.32M.
- 2023-09-30: Convertible Notes Payable, Noncurrent $1.17M.
- 2023-06-30: Convertible Notes Payable, Noncurrent $1.14M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2024-06-30 | $1.32M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $1.17M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.14M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.11M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.08M 10-K · filed 2024-03-08 |
| 2022-09-30 | $1.06M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $979.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |